RS20050038A - Stabilization of the profile of release of active substances from a formulation - Google Patents

Stabilization of the profile of release of active substances from a formulation

Info

Publication number
RS20050038A
RS20050038A YUP-2005/0038A YUP20050038A RS20050038A RS 20050038 A RS20050038 A RS 20050038A YU P20050038 A YUP20050038 A YU P20050038A RS 20050038 A RS20050038 A RS 20050038A
Authority
RS
Serbia
Prior art keywords
profile
formulation
stabilization
release
active substances
Prior art date
Application number
YUP-2005/0038A
Other languages
English (en)
Inventor
Aleksander Resman
Darja Fercej Temeljotov
Vlasta Humar
Marko Opresnik
Original Assignee
Lek Farmacevtska Družba D.D.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Farmacevtska Družba D.D., filed Critical Lek Farmacevtska Družba D.D.,
Publication of RS20050038A publication Critical patent/RS20050038A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Pronalazak otkriva postupak za fizički pripremni tretman aktivne supstance, koji menja tehnološki značajne fizičke osobine aktivne supstance tako da omogućava proizvodnju formulacije sa stabilnijim profilom oslobadjanja aktivne supstance tokom celokupnog roka trajanja medikamenta u odnosu na profil koji bi isti sastav imao bez prethodnog pripremnog tretmana.
YUP-2005/0038A 2002-07-17 2003-07-15 Stabilization of the profile of release of active substances from a formulation RS20050038A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200200179A SI21256A (sl) 2002-07-17 2002-07-17 Stabilizacija profila sproščanja učinkovin iz formulacije
PCT/SI2003/000025 WO2004006888A2 (en) 2002-07-17 2003-07-15 Stabilization of the profile of release of active substances from a formulation

Publications (1)

Publication Number Publication Date
RS20050038A true RS20050038A (en) 2007-06-04

Family

ID=30113493

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2005/0038A RS20050038A (en) 2002-07-17 2003-07-15 Stabilization of the profile of release of active substances from a formulation

Country Status (10)

Country Link
US (1) US20060083759A1 (sr)
EP (1) EP1524965A2 (sr)
AU (1) AU2003248615B2 (sr)
HR (1) HRP20050040A2 (sr)
PL (1) PL372771A1 (sr)
RS (1) RS20050038A (sr)
RU (1) RU2354387C2 (sr)
SI (1) SI21256A (sr)
UA (1) UA89020C2 (sr)
WO (1) WO2004006888A2 (sr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2283824B1 (en) * 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin
CN108853039B (zh) * 2018-08-07 2021-03-09 河北君临药业有限公司 一种克拉霉素分散片及其生产工艺

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
CA2039742A1 (en) * 1990-04-23 1991-10-24 Andrew B. Dennis Tablet composition and method for problem pharmaceutical materials
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
US5919489A (en) * 1995-11-01 1999-07-06 Abbott Laboratories Process for aqueous granulation of clarithromycin
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
SI20150A (sl) * 1999-02-19 2000-08-31 Lek, Tovarna Farmacevtskih In Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina
BR0109194A (pt) * 2000-03-15 2003-02-11 Hanmi Pharm Ind Co Ltd Método para preparar claritromicina em cristais da forma ii
US6899890B2 (en) * 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system

Also Published As

Publication number Publication date
WO2004006888A2 (en) 2004-01-22
UA89020C2 (ru) 2009-12-25
EP1524965A2 (en) 2005-04-27
AU2003248615B2 (en) 2006-11-16
PL372771A1 (en) 2005-08-08
RU2005104423A (ru) 2006-01-27
RU2354387C2 (ru) 2009-05-10
WO2004006888A3 (en) 2004-04-29
HRP20050040A2 (en) 2006-11-30
AU2003248615A1 (en) 2004-02-02
SI21256A (sl) 2004-02-29
US20060083759A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
RS20060320A (en) Substituted indazole-o-glucosides
MY142777A (en) Substituted indole-o-glucosides
UA87991C2 (en) Substituted indole-o-glucosides
MX2010002285A (es) Combinaciones de principios activos con propiedades insecticidas y acaricidas.
WO2005012242A3 (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
PE20081506A1 (es) Formulaciones de ansamicina
MY138708A (en) Biaryloxymethylarenecarboxylic acids
MY153915A (en) Organic compounds
UY33397A (es) Forma sólida de un naftaleno carboxamida
EA201000089A1 (ru) Применение гомо- и сополимеров для стабилизации составов активных ингредиентов
NO20090596L (no) Antivirale fosfinatforbindelser
NO20055130L (no) Aminocykloheksyleter-forbindelser og deres anvendelse
MX2009007337A (es) Indazoles sustituidos con 5-piridinona.
EP1670450B8 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
TW200633992A (en) Biaryloxymethylarenecarboxylic acids
TW200800967A (en) Benzimidazole thiophene compounds
UA89315C2 (en) Butylbenzene phthalein intravenous emulsion
DK1268498T3 (da) Kardioprotektive phosphater
EA200800698A1 (ru) Способ стабилизации фармацевтических форм для введения, включающих микроорганизмы
EP1812112A4 (en) CHEMICAL COMPOUNDS
WO2008073332A3 (en) Creatine compositions for skin treatment
MX2007006042A (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
NO20082848L (no) Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre
RS20050038A (en) Stabilization of the profile of release of active substances from a formulation